Cardiff Oncology, Inc. CRDF
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2004-07-27
Cardiff Oncology, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 2,628,407 | $5.8M |
| CITADEL ADVISORS LLC | 354,566 | $574,397 |
| TWO SIGMA INVESTMENTS, LP | 206,990 | $335,324 |
| RENAISSANCE TECHNOLOGIES LLC | 101,253 | $164,030 |
| AQR CAPITAL MANAGEMENT LLC | 66,156 | $107,173 |
| MILLENNIUM MANAGEMENT LLC | 23,029 | $37,307 |
Source: SEC EDGAR filings · CIK 0001213037 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.